Literature DB >> 5061074

Psychosis during methylphenidate abuse.

J Spensley, D A Rockwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5061074     DOI： 10.1056/NEJM197204202861607

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Foreword -- ADHD in the scientific and political context.

Authors:  Jan K Buitelaar; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

2.  Olanzapine, a novel atypical antipsychotic, reverses d-amphetamine-induced inhibition of midbrain dopamine cells.

Authors:  M E Stockton; K Rasmussen
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

Review 3.  Use of Stimulants in Bipolar Disorder.

Authors:  Giulio Perugi; Giulia Vannucchi; Fulvio Bedani; Ettore Favaretto
Journal:  Curr Psychiatry Rep       Date:  2017-01       Impact factor: 5.285

Review 4.  Delusional infestation.

Authors:  Roland W Freudenmann; Peter Lepping
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

5.  Methylphenidate Abuse and Psychiatric Side Effects.

Authors:  W Alexander Morton; Gwendolyn G. Stockton
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-10

6.  Prevalent intravenous abuse of methylphenidate among treatment-seeking patients with substance abuse disorders: a descriptive population-based study.

Authors:  Gudrun D Bjarnadottir; Haraldur M Haraldsson; Bjarni O Rafnar; Engilbert Sigurdsson; Steinn Steingrimsson; Magnus Johannsson; Helena Bragadottir; Andres Magnusson
Journal:  J Addict Med       Date:  2015 May-Jun       Impact factor: 3.702

Review 7.  Reframing delusional infestation: perspectives on unresolved puzzles.

Authors:  Jianbo Lai; Zhe Xu; Yi Xu; Shaohua Hu
Journal:  Psychol Res Behav Manag       Date:  2018-10-01

Review 8.  From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate.

Authors:  Francesco Paolo Busardò; Chrystalla Kyriakou; Luigi Cipolloni; Simona Zaami; Paola Frati
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.